Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
– Sell
-11,900
Closed -$1.18M – 107
2019
Q3
$1.18M Hold
11,900
– – 0.75% 18
2019
Q2
$1.1M Buy
+11,900
New +$1.13M 0.47% 52

Other funds holding CELG

Polianta Ltd's CELG Position: Q4 2019 in Review

Polianta Ltd sold out of Celgene (CELG) in Q4 2019, closing a stake of 11,900 shares — an estimated $1.18M sold.

Polianta Ltd first reported a position in CELG in Q2 2019 and held it in 2 quarters. The position peaked at $1.18M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Polianta Ltd reported no remaining Celgene position as of Q4 2019 after selling out during the quarter.
  • Polianta Ltd sold 11,900 Celgene shares in Q4 2019, an estimated $1.18M.
  • Polianta Ltd first reported a position in Celgene in Q2 2019 and held it in 2 quarters.
  • Polianta Ltd's Celgene position peaked at $1.18M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene as of Q4 2019.

Based on Polianta Ltd's 13F filing for Q4 2019, filed 13 Jan 2020.